NMPA Approval

Emtricitabine and Tenofovir Alafenamide Fumarate Tablets(Ⅱ)

Approval Number

国药准字H20249175

Company正大天晴药业集团股份有限公司

Registration Date

October 22, 2024

Drug Information

Generic Name

恩曲他滨丙酚替诺福韦片(Ⅱ)

Dosage Form

片剂

Strength

每片含200mg恩曲他滨，25mg丙酚替诺福韦。

Drug Type

化学药品

Registration Date

October 22, 2024

Company Information

Applicant Company

Company Name正大天晴药业集团股份有限公司

Company Address

江苏省连云港市郁州南路369号

Manufacturing Company

Company Name正大天晴药业集团股份有限公司

Company Address

江苏省连云港市郁州南路369号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

恩曲他滨丙酚替诺福韦片(Ⅱ) - NMPA 批准文号 | MedPath